DE60140051D1 - Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen - Google Patents

Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen

Info

Publication number
DE60140051D1
DE60140051D1 DE60140051T DE60140051T DE60140051D1 DE 60140051 D1 DE60140051 D1 DE 60140051D1 DE 60140051 T DE60140051 T DE 60140051T DE 60140051 T DE60140051 T DE 60140051T DE 60140051 D1 DE60140051 D1 DE 60140051D1
Authority
DE
Germany
Prior art keywords
mobilization
human growth
pluripotental
stimulating
stem cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60140051T
Other languages
German (de)
English (en)
Inventor
Alessandro Massimo Gianni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Serono SA
Original Assignee
Merck Serono SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono SA filed Critical Merck Serono SA
Application granted granted Critical
Publication of DE60140051D1 publication Critical patent/DE60140051D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/27Growth hormone [GH], i.e. somatotropin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60140051T 2000-06-07 2001-06-01 Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen Expired - Lifetime DE60140051D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00111834 2000-06-07
PCT/EP2001/006249 WO2001093900A1 (en) 2000-06-07 2001-06-01 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Publications (1)

Publication Number Publication Date
DE60140051D1 true DE60140051D1 (de) 2009-11-12

Family

ID=8168902

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60140051T Expired - Lifetime DE60140051D1 (de) 2000-06-07 2001-06-01 Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen

Country Status (10)

Country Link
US (1) US20040028649A1 (https=)
EP (1) EP1286689B1 (https=)
JP (1) JP2003535144A (https=)
AT (1) ATE444078T1 (https=)
AU (2) AU8180001A (https=)
CA (1) CA2409197A1 (https=)
DE (1) DE60140051D1 (https=)
ES (1) ES2330193T3 (https=)
IL (1) IL153288A0 (https=)
WO (1) WO2001093900A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091311B2 (en) * 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
EP1016413A1 (en) * 1998-12-30 2000-07-05 Applied Research Systems ARS Holding N.V. Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
US7288521B2 (en) * 2000-04-06 2007-10-30 Franco Wayne P Growth factor therapy mobilization of stem cells into the peripheral blood
CA2467557A1 (en) * 2001-11-19 2003-05-30 Kyowa Hakko Kogyo Co., Ltd. Agent which mobilizes multipotential stem cells from tissues to peripheral blood
ES2781475T3 (es) 2002-09-18 2020-09-02 Janssen Pharmaceuticals Inc Métodos para aumentar la producción de células madre hematopoyéticas y plaquetas
US20040149235A1 (en) * 2002-10-04 2004-08-05 Pogue Albert S. Apparatus and method for removal of waste from animal production facilities
WO2005017160A2 (en) * 2003-08-13 2005-02-24 Children's Hospital Medical Center Mobilization of hematopoietic cells
WO2005017161A2 (en) 2003-08-13 2005-02-24 Children's Hospital Medical Center Chimeric peptides for the regulation of gtpases
US9011880B2 (en) 2003-10-21 2015-04-21 Igf Oncology, Llc Compounds and methods for treating cancer
CA2542834C (en) 2003-10-21 2012-04-24 Igf Oncology, Llc Conjugates or co-administration of igf-1 receptor ligands with anti-cancer chemotherapeutic agents
WO2005072292A2 (en) * 2004-01-24 2005-08-11 Hugh Mctavish Methods for enhancing radiation therapy
US7615533B2 (en) * 2004-08-16 2009-11-10 Janssen Pharmaceutica N.V. TPO peptide compounds for treatment of anemia
WO2006047214A2 (en) 2004-10-21 2006-05-04 Igf Oncology, Llc Toxins and radionuclides coupled to igf-1 receptor ligands for treatment of cancer
CA2677813A1 (en) * 2007-02-13 2008-08-21 Helsinn Therapeutics (U.S.), Inc. Method of treating cell proliferative disorders using growth hormone secretagogues
US20100226894A1 (en) * 2009-03-09 2010-09-09 Alex Wah Hin Yeung Mobilization of a complete cells mixture with embryonic like stem cells from the peripheral blood
SG192254A1 (en) * 2011-01-31 2013-08-30 Royal Medical Group Pllc Pluripotent stem cells and method of stimulating and extracting non-embryonic pluripotent stem cells from mammal blood and using reconstituted pluripotent stem cells to treat diseases including chronic obstructive pulmonary disease
WO2012131733A2 (en) * 2011-03-31 2012-10-04 Godavari Biorefineries Limited Media compositions, method of initiating and enriching cultures of stem cells and/or cancer stem-like cells
CN104302670A (zh) 2012-02-07 2015-01-21 Phi生物医药股份有限公司 制造用于经皮给药的透明质酸-蛋白结合体的方法以及由该方法制造的用于经皮给药的透明质酸-蛋白结合体
CA2936675C (en) 2014-01-12 2023-06-27 Igf Oncology, Llc Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof
CN117442747A (zh) 2017-05-21 2024-01-26 Igf肿瘤公司 胰岛素样生长因子——用于治疗骨髓增生异常综合症的化学治疗缀合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19549232C2 (de) * 1995-12-20 1998-05-20 Boehringer Mannheim Gmbh Verwendung von G-CSF in Kombination mit einem Chemotherapeutikum bei der Behandlung von Erkrankungen, die eine periphere Stammzelltransplantation erfordern
EP1016414B1 (en) * 1998-12-17 2004-09-08 Applied Research Systems ARS Holding N.V. Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans
EP1016413A1 (en) * 1998-12-30 2000-07-05 Applied Research Systems ARS Holding N.V. Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Also Published As

Publication number Publication date
AU2001281800B2 (en) 2005-12-22
US20040028649A1 (en) 2004-02-12
JP2003535144A (ja) 2003-11-25
ES2330193T3 (es) 2009-12-07
WO2001093900A1 (en) 2001-12-13
CA2409197A1 (en) 2001-12-13
EP1286689A1 (en) 2003-03-05
IL153288A0 (en) 2003-07-06
EP1286689B1 (en) 2009-09-30
ATE444078T1 (de) 2009-10-15
AU8180001A (en) 2001-12-17

Similar Documents

Publication Publication Date Title
DE60140051D1 (de) Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen
BR112021021165A2 (pt) Conjugados anticorpo-fármaco de amatoxina e uso dos mesmos
ATE286118T1 (de) Anwendungen für humane nicht autologe, mesenchymale stammzellen
GB2434157A (en) Platelets from stem cells
CY1111727T1 (el) Βλαστοκυτταρα, τα οποια λαμβανονται απο πολφο νεογιλων ή μονιμων οδοντων και οδοντικους βλαστους, ικανα να παραγουν ανθρωπινο οστικο ιστο
HUP0400371A2 (hu) Szén-monoxid alkalmazása szerv átültetés utáni túlélésének vagy működésének javítására alkalmas gyógyszerkészítmény előállítására
WO2004096975A3 (en) Apparatus and methods for amplification of blood stem cell numbers
HUP0203781A2 (hu) Májszövet-forrás
WO2005044179A8 (en) Formulations containing astragalus extracts and uses thereof
Samiei et al. The effect of electromagnetic fields on survival and proliferation rate of dental pulp stem cells
CY1118073T1 (el) Συνθεσεις και μεθοδοι για την αυξηση της δρασης της τελομερασης
RU2006145431A (ru) Композиция для репарации хрящевой и костной ткани
ATE527378T1 (de) Antisense-modulation von p38-mitogen-aktivierter proteinkinase-expression
DE69634982D1 (de) Verfahren zur steigerung von hematopoietischen zellen
ATE277628T1 (de) Behandlung von hematopoietischen zellen mit cxcr4 agonisten
ATE348876T1 (de) Verfahren zur vermehrung von natürlichen killerzellen
IL156628A (en) Use of nk t cells in medical preparation, preparations containing nk t cells and their use in the treatment of immune-related disorders
RU2006146795A (ru) Композиция для стимулирования роста и регенерации клеток, а также способы ее получения
CY1107603T1 (el) Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης
WO2021015615A8 (en) Low density cell culture
DK1788078T3 (da) Dendritisk celle-lægemiddel indeholdende den dendritiske celle, terapeutisk fremgangsmåde under anvendelse af den dendritiske celle og fremgangsmåde til dyrkning af gammadelta-T-celle
ATE225183T1 (de) Verwendung von hepatozyten-wachstumsfaktor zur induzierung der proliferation und differenzierung von hämatopoietischen zellen
WO2009116088A3 (en) Stem cell composition for inducing transplant tolerance
WO2024077153A8 (en) Pluripotent stem cell-derived megakaryocytes and platelets
ATE431399T1 (de) Verwendung von cytokinen, zellen und mitogene zur hemmung der graft-versus-host krankheit

Legal Events

Date Code Title Description
8364 No opposition during term of opposition